Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| squamous epithelial cell | 3 studies | 34% ± 16% | |
| mesothelial cell | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of CPA4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 83% | 561.36 | 215 / 258 | 62% | 3.50 | 142 / 230 |
| pancreas | 100% | 1026.11 | 328 / 328 | 42% | 1.94 | 74 / 178 |
| skin | 91% | 3501.49 | 1645 / 1809 | 33% | 2.97 | 155 / 472 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.07 | 1 / 1 |
| esophagus | 38% | 946.81 | 543 / 1445 | 58% | 13.50 | 106 / 183 |
| spleen | 92% | 459.54 | 222 / 241 | 0% | 0 | 0 / 0 |
| breast | 22% | 69.13 | 100 / 459 | 61% | 5.65 | 679 / 1118 |
| uterus | 3% | 82.16 | 5 / 170 | 69% | 23.86 | 315 / 459 |
| ovary | 0% | 0 | 0 / 180 | 54% | 2.81 | 232 / 430 |
| tonsil | 0% | 0 | 0 / 0 | 53% | 6.31 | 24 / 45 |
| kidney | 11% | 38.61 | 10 / 89 | 27% | 3.00 | 245 / 901 |
| lung | 5% | 50.56 | 29 / 578 | 32% | 4.02 | 364 / 1155 |
| bladder | 0% | 0 | 0 / 21 | 35% | 7.07 | 177 / 504 |
| adipose | 27% | 326.47 | 329 / 1204 | 0% | 0 | 0 / 0 |
| brain | 6% | 30.05 | 159 / 2642 | 20% | 0.69 | 140 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 0.27 | 5 / 29 |
| eye | 0% | 0 | 0 / 0 | 13% | 0.24 | 10 / 80 |
| stomach | 1% | 4.30 | 4 / 359 | 9% | 0.43 | 26 / 286 |
| intestine | 0% | 0.33 | 1 / 966 | 10% | 0.65 | 52 / 527 |
| liver | 0% | 0 | 0 / 226 | 7% | 0.32 | 29 / 406 |
| peripheral blood | 6% | 50.59 | 60 / 929 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0 | 0 / 653 | 6% | 0.19 | 38 / 605 |
| heart | 6% | 57.72 | 52 / 861 | 0% | 0 | 0 / 0 |
| muscle | 2% | 9.99 | 14 / 803 | 0% | 0 | 0 / 0 |
| prostate | 1% | 2.24 | 2 / 245 | 0% | 0.01 | 2 / 502 |
| blood vessel | 1% | 6.60 | 12 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043171 | Biological process | peptide catabolic process |
| GO_0006508 | Biological process | proteolysis |
| GO_0042447 | Biological process | hormone catabolic process |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005615 | Cellular component | extracellular space |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0004181 | Molecular function | metallocarboxypeptidase activity |
| Gene name | CPA4 |
| Protein name | Carboxypeptidase A4 (cDNA FLJ75086, highly similar to Homo sapiens carboxypeptidase A4, mRNA) Carboxypeptidase A4 (EC 3.4.17.-) (Carboxypeptidase A3) Carboxypeptidase A4 |
| Synonyms | tcag7.359 hCG_18973 CPA3 UNQ694/PRO1339 |
| Description | FUNCTION: Metalloprotease that could be involved in the histone hyperacetylation pathway . Releases a C-terminal amino acid, with preference for -Phe, -Leu, -Ile, -Met, -Tyr and -Val . . |
| Accessions | ENST00000486598.1 C9J3P4 ENST00000445470.6 [Q9UI42-2] Q9UI42 ENST00000473956.5 C9J6N7 ENST00000222482.10 [Q9UI42-1] B7Z5J4 ENST00000493259.5 C9J7D6 A4D1M3 ENST00000492072.5 |